HIV treatment has improved over the past few decades. Many people living with HIV can now lead long, healthy lives by taking ...

(Kateryna Kon/Science Photo Library/Getty Images) Scientists have just announced the results from the first clinical trial in people with HIV-1 of a new antiretroviral drug, which suggests it could be ...

ViiV Healthcare’s Dovato has been approved for use in the US and EU since 2019, but its sales remain overshadowed by Gilead’s ...

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for ...

Summary When potent antiretroviral drugs became available in the mid-1990s, a policy of "hit early, hit hard" guided their use: Experts endorsed treatment for all symptomatic HIV-infected patients and ...

In a report appearing in the July 12 issue of JAMA, an HIV/AIDS theme issue, Huldrych F. Gunthard, M.D., of University Hospital Zurich, Switzerland, and colleagues with the International Antiviral ...

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for ...

Effect of the Initial Regimen on the Rate of Specific Mutations Even among different HAART regimens, the selection of the initial regimen also has important implications in terms of selecting for ...

Please provide your email address to receive an email when new articles are posted on . Obesity led to reduced exposures across all antiretroviral drugs. Etravirine showed the highest change in ...

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a new study. Though clinical studies are necessary ...